VX-150 is a potent and selective small molecule inhibitor of the NaV1.8 sodium channel, demonstrating over 400-fold selectivity against other subtypes. This selectivity makes it a valuable research tool for investigating NaV1.8s role in pain signaling, both in cellular assays and in vivo models of neuropathic and inflammatory pain.